The Rise of Companion Diagnostics
Infographic Mar 17, 2017
Companion Diagnostics can identify patients who are most likely to benefit from a particular therapeutic, highlight those at increased risk for serious side effects as a result of treatment with a particular therapeutic, and monitor treatment response to a particular therapeutic.
Since the approval of Herceptin® in 1998, companion diagnostics have played a vital role in the safe and effective use of a corresponding drug.
Learn more about companion diagnostics including:
- the growth in the market
- the technologies used
- the challenges and benefits
- the future
Over the recent decades, science has witnessed the coupling of the neuroscience and genomics research fields to create a novel area known as neurogenomics. In this infographic, we explore how neurogenomics came to be, the methodologies commonly adopted in research studies and how it contributes to our understanding of neurological diseases.READ MORE